SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form C/A - Offering Statement: [Amend]
SEC Accession No. 0001669191-24-000204
Filing Date
2024-02-27
Accepted
2024-02-27 10:00:14
Documents
8

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C/A  
1 primary_doc.xml C/A 10214
2 OFFERING STATEMENT PDF offeringstatement.pdf EX-99 366951
3 OFFERING PAGE JPG offeringpage.jpg GRAPHIC 1776674
4 CPA AUDIT REPORT auditreport.pdf EX-99 363551
5 CERTIFICATE OF INCORPORATION certificateofincorporation.pdf EX-99 1044922
6 CORPORATE BYLAWS corporatebylaws.pdf EX-99 55960
7 ADDITIONAL INFORMATION otherfinancial.pdf EX-99 157305
8 IMAGE ATTACHMENTS HTML imageattachments.htm EX-99 244
  Complete submission text file 0001669191-24-000204.txt   5198712
Mailing Address 982A N. BATAVIA STREET SUITE 10B ORANGE CA 92867
Business Address 982A N. BATAVIA STREET, SUITE 10B ORANGE CA 92867 5622098912
Rejuve Biotech Inc. (Filer) CIK: 0001994911 (see all company filings)

IRS No.: 932218283 | State of Incorp.: DE | Fiscal Year End: 1231
Type: C/A | Act: 33 | File No.: 020-33659 | Film No.: 24682892